• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型177Lu放射性药物的体内剂量评估及其在患者辐射防护中的作用

Internal Dose Assessment of New 177Lu-Radiopharmaceuticals and Its Role in Radiation Protection of Patients.

作者信息

Yepes Nancy Puerta, Rojo Ana, Gossio Sebastián, Crudo José Luis

机构信息

Nuclear Regulatory Authority (ARN), Av. del Libertador 8250, Ciudad Autónoma de Buenos Aires C1429BNP, República Argentina.

National Atomic Energy Commission (CNEA), Presbítero González y Aragón 15, Ezeiza B1802AYA, República Argentina.

出版信息

Radiat Prot Dosimetry. 2017 Apr 1;173(1-3):192-197. doi: 10.1093/rpd/ncw317.

DOI:10.1093/rpd/ncw317
PMID:27885083
Abstract

Since 2006, CNEA has been conducting studies on the production, labeling, quality control and NIH mice biodistribution of several radiopharmaceuticals based on 177Lu locally produced. In order to contribute to ensuring the radiation protection of patients, the Internal Dosimetry Laboratory of the ARN has been complementing the preclinical study performing a dose assessment. This assessment included: the activity biodistribution analysis in NIH mice, the estimation of the absorbed dose, the extrapolation of the results to humans, the identification of healthy organs with high risk and the estimation of the maximum activity that can be administered to a patient without exceeding the threshold of radiotoxicity in healthy organs. It can be observed that internal dosimetry assessment has an important role for ensuring radiation protection in patients, since treatment parameters can be optimized out of the estimation of the maximum activity to be administered to the patient.

摘要

自2006年以来,阿根廷国家原子能委员会一直在对几种基于本地生产的177镥的放射性药物的生产、标记、质量控制和NIH小鼠生物分布进行研究。为了有助于确保患者的辐射防护,阿根廷放射与核能研究所的内照射剂量测定实验室一直在通过进行剂量评估来补充临床前研究。该评估包括:NIH小鼠体内放射性活度生物分布分析、吸收剂量估计、结果外推至人体、识别高风险健康器官以及估计在不超过健康器官放射性毒性阈值的情况下可给予患者的最大放射性活度。可以看出,内照射剂量测定评估对于确保患者的辐射防护具有重要作用,因为可以根据估计的要给予患者的最大放射性活度来优化治疗参数。

相似文献

1
Internal Dose Assessment of New 177Lu-Radiopharmaceuticals and Its Role in Radiation Protection of Patients.新型177Lu放射性药物的体内剂量评估及其在患者辐射防护中的作用
Radiat Prot Dosimetry. 2017 Apr 1;173(1-3):192-197. doi: 10.1093/rpd/ncw317.
2
A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.一种用于大鼠器官剂量测定的程式化计算模型,以支持用(90)钇、(111)铟或(177)镥进行肽受体放射性核素治疗的临床前评估。
J Nucl Med. 2004 Jul;45(7):1260-9.
3
Practical aspects of peptide receptor radionuclide therapy with [177Lu][DOTA0, Tyr3]octreotate.使用[177Lu][DOTA0, Tyr3]奥曲肽进行肽受体放射性核素治疗的实践方面。
Q J Nucl Med Mol Imaging. 2006 Dec;50(4):265-71.
4
Evaluation of beta-absorbed fractions in a mouse model for 90Y, 188Re, 166Ho, 149Pm, 64Cu, and 177Lu radionuclides.在小鼠模型中对90Y、188Re、166Ho、149Pm、64Cu和177Lu放射性核素的β吸收分数评估。
Cancer Biother Radiopharm. 2005 Aug;20(4):436-49. doi: 10.1089/cbr.2005.20.436.
5
Biodistribution and radiation dosimetry of radioiodinated hypericin as a cancer therapeutic.放射性碘化金丝桃素作为癌症治疗剂的生物分布和辐射剂量学。
Int J Oncol. 2014 Mar;44(3):819-29. doi: 10.3892/ijo.2013.2217. Epub 2013 Dec 17.
6
An internal radiation dosimetry computer program, IDAC 2.0, for estimation of patient doses from radiopharmaceuticals.一种用于估算放射性药物对患者剂量的体内辐射剂量学计算机程序IDAC 2.0。
Radiat Prot Dosimetry. 2014 Dec;162(3):299-305. doi: 10.1093/rpd/nct337. Epub 2013 Dec 18.
7
177Lu-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivo.用于体外单细胞杀伤B淋巴瘤细胞及体内微转移灶治疗的177Lu抗体偶联物
Nucl Med Biol. 2005 Apr;32(3):269-78. doi: 10.1016/j.nucmedbio.2005.01.003.
8
Pharmacokinetics and biodistribution of 111In- and 177Lu-labeled J591 antibody specific for prostate-specific membrane antigen: prediction of 90Y-J591 radiation dosimetry based on 111In or 177Lu?针对前列腺特异性膜抗原的111铟和177镥标记的J591抗体的药代动力学和生物分布:基于111铟或177镥预测90钇-J591的辐射剂量测定?
J Nucl Med. 2005 Apr;46(4):634-41.
9
Radiation absorbed doses to the walls of hollow organs.
J Nucl Med. 1998 Nov;39(11):1989-95.
10
Production, quality control, and determination of human absorbed dose of no carrier added Lu-risedronate for bone pain palliation therapy.用于骨痛缓解治疗的无载体添加的鲁利膦酸镥的生产、质量控制及人体吸收剂量测定。
J Labelled Comp Radiopharm. 2017 Jan;60(1):20-29. doi: 10.1002/jlcr.3466. Epub 2016 Nov 15.